The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
It doesn't matter. We are not looking for Warren Buffet investing here. We have our first institutional investor and more will come.
They have taken a large stake based on research and potential. That is all that matters. They will know more than we do.
The market cap was 0.5 million due to the situation at the time therefore to raise decent money at those low prices is next to impossible. They did well to only have 130 million now although it could have been lower.
Get some more new out ideally some lab revenue and focus on bringing one more institutional investor in and get the SP moving.
They would know nothing is factored in at this price. All the below would be very significant relative to our current price.
1) Outcomes of evaluation projects leading to SPV if successful
2) 201 deal conclusion
3) Several lab contracts
4) CLX update
5) 401 deal conclusion
We will get news on this positive or negative but most of this should be positive. They can see the potential from this low price.
The first is always the most difficult. More will come as they start to generate revenue or complete a deal and the share price will start moving.
I am particularly looking forward to the CLX update which is due early this year. A few decent lab contracts are highly likely very soon and 201 is still on. Great price to buy with very limited risk.
It's not easy to build a company from scratch so although I am down I give them some credit and feel that now with the foundations in place the share price will move forward at a decent pace.
The foundations are in place and I am sure we will also get some lab contracts which will attract investment given the value of the strategy. All Suzy needs to do is get another large investor buying in the open market and and this will fly.
The big ones are CLX and 201 and I think we will get news on that in the coming weeks. With a 5 million market cap and cash until 2025 I would fancy my chances of double digits at least.
I feel those buying here will do well over the coming months. The negative ones will just be buying at a much higher price. DYOR.
If you can get one then you can get more than one. Just needs a bit of lab revenue and maybe a CLX update then you can bring them in as Valirx has plenty of value on offer at this market cap.
201 would be a huge bonus but like Adam said we have about 5 projects including the lab that can really bring significant value hopefully in the coming weeks/months I would think.
The current SP should be at the bottom now with all this positive news and more to come.
Here is the ultimate lie and bullchit by AIM's biggest deramper Porky. You pick and choose what you want but the facts are below.
Porky's comment
The broker reports have proven accurate every time without exception for when the cash runway runs out. I have zero reason to suspect it will be any different now. Hence on current trajectory they will need to raise in September.
But from Turner Pope recent note:
Cash runway now appears sufficient to carry it well into 2025
Full year 2023E Group net losses along with the cost of establishing/facilitating Inaphaea Biolabs (including the
acquisition of Imagen Therapeutics), resulted in an average estimated cash burn of a little over £200,000/month for
the period. If one now prudently assumes further, albeit somewhat reduced, Group net losses for 2024E, during
which time it utilises the newly raised net funding to accelerate exploitation and integration of its acquired BioBank
materials in tandem with commercial development/brand establishment within Inaphaea while also advancing
its preclinical product pipeline in the absence of further cash acquisition(s), the Group now appears to have runway
sufficient to carry it into Q2 2025.
Between now and then, of course, various upside scenarios suggest this period could become significantly extended.
This could be derived through securing higher volumes of fee-paying service customers for Inaphaea, potential
signing of licensing agreements with external parties willing to pay upfront charges and fund ongoing
development of the Group’s preclinical and/or clinical assets which, in turn, could also attract continuing
milestones instalments. Any such outcome could be both transformative for ValiRx’s balance sheet while also
proving its business model.
Projected based on broker report Q2 FY2025. They will get some decent lab revenue over the year so maybe end of the year.
201 remains in place so the extra 2 million takes it to 2026.
At the end of the day all that matters is delivery. If the SP goes to where it should be then it is nothing.
At least try and understand the conversation Nick. You can't even do that because it was not me that said it.
You admitted yourself that you have minimal investment compared to the past. You can afford to buy if this crashed at our expense. If you don't believe in the company then why are you even here.
You and Porky are the last people that I would listen to.
Anyway pointless. Not going to argue with those that have agendas.
The merger should still be complete successfully given all the work that has been done so all these arguments are irrelevant. If they announce a LOI then it is ongoing unless an RNS says otherwise.
The only issue being lack of update but that is self inflicted by the BOD in my opinion as they should be feeling back to TRX so that EUDA releases an update.
Later for now. Waste of time as only the outcome of the merger is what matters and it is not priced in anyway.
I see you were invested in HE1?
How much did the CEO invest before the news which took it above 1000%? Sorry it happens across AIM. Not really a reflection of reality plus I guess she was hoping for cheap options.
You need to convince yourself before convincing others.
So just recently you were claiming 99 % believe 201 is happening now you are saying it is not. Seems you are the thick one changing one thing to the other.
betterlife
Posted in: VAL
Posts: 279
Price: 8.10
Strong Buy
The gang of badgers11 Dec 2023 19:49
porky, soon i will get under your skin.it is christmas soon as you know.people who panics and sells on here must be following you everywhere .they still haven’t learned the lesson from your mistakes one after the other.1p drop they absolutely **** them self,2p rise they go over the moon.just because you pay £20,90 shillings a month ,doesn’t means that you are professional trader or know a faak all.you have been saying last 2 years they will rise at 4p. you are absolutely full off…. so many new babies on here reads your post they think you know all but unfortunately you don’t know f. all.when price is down your other allies nick also appears on the stage for some reason . nick also says on telegram that he doesn’t pay you for rubbish you dump on here , how weird!!you need to change the tactic anymore. you have been so boring. possibly most boring human/she on planet.i love dr adam’s replay your post on twitter says “get help” which most of us have been telling last 2-3 years.%99 of share holders believes val 201 is happening.you have got nothing to invest anymore because you lost all.i look your history, any shares you have been on, has gone bust or about to go bust.there isn’t any advice i can give you but, i can definitely recommend you to see a doctor. if you don’t have money to see doctor , i am sure dr adam will be very kind to see you. he is very generous man.
Not really. As stated yesterday for the merger to go ahead you likely need the board as it is at the moment so the merger goes ahead and the sub license gets executed following the conclusion of the merger.
Let the merger conclude and give it another month or two otherwise you are just shooting yourself in the foot. No point screwing it up on the finishing line after all this time.
Frustration should not get in the way of making stupid decisions at the wrong time. To be fair I don't even know who is really invested on these boards but I have a good idea of those that are not.
201 needs to conclude unless you want to release 1 billion shares at 1p next year. Conclusion of that can take the share price to any price along with other news.
New projects need funding and the 2 million 201 gives even more time for a CLX deal therefore potentially even meaning no placing for a very long time. The share price can hit all time highs if 201, 401 and CLX get completed but for that to happen we will likely need to 201 over the line first.
We got cash so we can wait a month or two and as far as I am concerned TRX has raised the money based on my analysis of all the statements released so far. Unless it is a scam which I highly doubt.
Ok let me piece all together all in my opinion but I think it makes sense.
1) Valirx would only sign the sub license if TRX had the money in place to pay Valirx the agreed amounts and for that to happen they would also need to have funding in place for the trials. Otherwise Valirx cannot sign the sub license.
2) The RNS on the 28 Sept 2023 confirmed that Valirx will receive the payments once the sub license was signed.
3) Suzy stated it should be a straightforward and fairly quick process to sign the sub licence once the merger is completed.
4) Public statement released by EUDA regarding TRX financing:
“We believe TheoremRx has strong access to capital and a robust pipeline of compounds addressing high-demand unmet therapeutic areas with near-term inflection points. Its project portfolio is also pre-selected for high upside, with minimal time and cost to reach key monetization milestones. By combining the respective strengths of our two companies’ platforms, we believe that we can help critical new biopharma treatments advance through the clinical trial process while creating significant value for shareholders.”
5) Although it says they believe if it was not the case TRX had the funding then the DD would very likely have failed by now.
Many of those that are posting here are not really invested so are not acting in our best interests.
My view is that action at this time is counter productive and would jeopardise the deal unless like I said it is Adam that comes on board. If it was any other shareholder I would question what they would bring to the table because as I am concerned they can give themselves options at any time at any price and if the share price is at a certain price then shareholders would likely have to agree. They collect an easy wage and walk away whilst we hold onto the baby at lower prices. It would just be a repeat of Suzy 3 years back.
If no delivery happens by the end of March or if the deal fails then it's fair to make some changes but I question it at this stage.
The merger needs the LOI in place if that is in doubt due to an EGM that would likely mean further delays or the merger being put at risk.
If this was near the start of the LOI i would agree but not at the concluding stage. That can only be tested by waiting a few weeks longer closer to the end of March although that is not an official deadline.
I have no doubt TRX has raised the funds so all this is not helpful at this time. Change might be good depending on the outcome but the timing is wrong so I would vote against it for now if it comes to it. It just creates more instability at the wrong time.
This does not favour existing holders but I don't see anyone selling in fact we might see buyers. Those here calling for change will nicely walk away if 201 failed so I don't think this helps the situation at this time.
As I said numerous times I would have waited until 31st March but I would think the outcome of the merger would be much sooner. If that failed then I would have pushed for changes as the damage would be at a point where it could not get worse.
I see it as a huge positive if it is Adam stepping forward but I don't want another Suzy or two. No time for apprentices and those trying to get a cheap salary and options.